drugset / Trial / NCT07402551
Phase II Study of RC1416 Injection in COPD
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multicenter, randomized, double-blind, placebo-controlled phase II clinical study to evaluate the efficacy and safety of RC1416 injection in patients with moderate to severe chronic obstructive pulmonary disease (COPD).
Timeline
- Start
- 2026-03-06
- Primary completion
- 2028-05-31
- Completion
- 2028-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RC1416 | Protein / enzyme biologic | — | Subcutaneous |